The safety and efficacy of MK0724 will be assessed in patients with acute middle cerebral artery stroke using the Action Reach Arm Test (ARAT). This test allows measurement of a specific functional deficit and subsequent recovery correlating with the specific area of stroke in the brain.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
150
Placebo IV infusions 1hr/daily over 7 days.
MK0724 8 mg/kg/hr 1 hr/daily over 7 days.
Action Research Arm Test score
Time frame: At 90 days
Scores on the Stroke Arm Strength question, modified Rankin, and Barthel Index.
Time frame: At 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.